Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA stratified by age and renal function: CHANCE-2 trial substudy.
Saved in:
| Title: | Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA stratified by age and renal function: CHANCE-2 trial substudy. |
|---|---|
| Authors: | Wu, Yu1 (AUTHOR), Zhou, Yilun1 (AUTHOR), Pan, Yuesong2,3 (AUTHOR), Jin, Aoming2,3 (AUTHOR), Meng, Xia2,3 (AUTHOR), Li, Hao2,3 (AUTHOR), Wang, Yilong2,3 (AUTHOR), Jiang, Yong2,3 (AUTHOR), Wang, Yongjun2,3 (AUTHOR) yongjunwang@ncrcnd.org.cn |
| Source: | Renal Failure. Dec2025, Vol. 47 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
